lexiara

Article 21

An authorisation to market a proprietary medicinal product shall not be refused, suspended or revoked except on the grounds set out in this Directive.

Cited at article level by

Second Council Directive 75/319/EEC of 20 May 1975 on the… (EU) — sign in to see which provisions, and what they say.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-05 · Text as adopted (Official Journal); later amendments are not incorporated in this text.